Roche Deploys NVIDIA AI Factory Globally with Over 3,500 Blackwell GPUs to Accelerate Drug Discovery, Diagnostics, and Manufacturing Innovation

As a leading enterprise in the healthcare sector, Roche is putting its commitment to “staying one step ahead to meet patients’ future needs” into practice by deploying more than 3,500 NVIDIA Blackwell GPUs globally and deeply integrating them across its entire value chain, thereby achieving comprehensive leaps in R&D efficiency, next-generation diagnostic technologies, and manufacturing capabilities.

Roche is deploying more than 3,500 NVIDIA Blackwell GPUs across hybrid cloud and on-premises environments in the United States and Europe, further deepening its existing partnership with NVIDIA to establish AI and accelerated computing as core operational capabilities throughout its pharmaceuticals and diagnostics businesses.

At last week’s NVIDIA GTC, Roche demonstrated how this new AI computing infrastructure empowers end-to-end innovation—from biological foundation models and drug discovery to manufacturing digital twins.

This investment provides Roche with the large-scale computing power needed to enable its research teams to undertake the most forward-looking and ambitious scientific projects.

• Leveraging NVIDIA Blackwell running in its AI factory andNVIDIA BioNeMoPlatform, Roche can train and fine-tune biological and molecular foundation models, integrate proprietary datasets, and expand AI-driven laboratory automation capabilities, thereby fully empowering the closed-loop laboratory strategy.




• Roche is still utilizingNVIDIA OmniverseKuei advances the modernization of pharmaceutical manufacturing by creating digital twins of production facilities to simulate and optimize complex systems before actual commissioning. These virtual environments have played a significant role in accelerating the construction and development of Roche’s next-generation GLP-1 manufacturing plant in North Carolina.




• Leveraging accelerated computing andNVIDIA Parabrickssoftware, Roche can extract key insights from massive amounts of data. In the field of digital pathology, NVIDIA technology can scan and analyze large volumes of images to identify subtle disease patterns; in the realm of digital health, Roche adoptsNVIDIA NeMo GuardrailsEnsure the safety and reliability of AI to meet medical-grade standards.

The above is the abstract. Click “Read Full Article” or scan the QR code below to read the complete content: